RCAMU
SYNH

Rothschild & Co Asset Management US’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Rothschild & Co Asset Management US’s Portfolio SYNH Stock Details SYNH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-74,764
Closed -$3.52M – 266
2022
Q3 		$3.52M Sell
74,764
-20,912
-22% -$1.35M 0.06% 206
2022
Q2 		$6.86M Sell
95,676
-5,917
-6% -$433K 0.11% 154
2022
Q1 		$8.22M Sell
101,593
-55,939
-36% -$4.73M 0.11% 158
2021
Q4 		$16.2M Sell
157,532
-1,533
-1% -$147K 0.19% 131
2021
Q3 		$13.9M Sell
159,065
-86,955
-35% -$7.87M 0.17% 147
2021
Q2 		$22M Sell
246,020
-19,385
-7% -$1.64M 0.26% 116
2021
Q1 		$20.1M Sell
265,405
-108,166
-29% -$8.15M 0.25% 125
2020
Q4 		$25.5M Sell
373,571
-70,878
-16% -$4.42M 0.33% 99
2020
Q3 		$23.6M Sell
444,449
-77,169
-15% -$4.6M 0.43% 92
2020
Q2 		$30.4M Sell
521,618
-134,619
-21% -$7.23M 0.45% 67
2020
Q1 		$25.9M Sell
656,237
-77,974
-11% -$4.56M 0.4% 92
2019
Q4 		$43.7M Sell
734,211
-45,144
-6% -$2.43M 0.45% 74
2019
Q3 		$41.5M Sell
779,355
-9,681
-1% -$497K 0.45% 73
2019
Q2 		$40.3M Buy
789,036
+205,947
+35% +$9.59M 0.43% 80
2019
Q1 		$30.2M Buy
583,089
+386,294
+196% +$18.7M 0.32% 114
2018
Q4 		$7.74M Buy
196,795
+9,543
+5% +$443K 0.09% 269
2018
Q3 		$9.65M Sell
187,252
-4,033
-2% -$197K 0.1% 271
2018
Q2 		$8.97M Buy
191,285
+4,336
+2% +$179K 0.1% 274
2018
Q1 		$6.64M Sell
186,949
-488,735
-72% -$19.1M 0.07% 276
2017
Q4 		$29.5M Buy
675,684
+40,428
+6% +$1.89M 0.31% 134
2017
Q3 		$33.2M Buy
635,256
+144,105
+29% +$8.04M 0.37% 103
2017
Q2 		$28.7M Buy
491,151
+30,291
+7% +$1.57M 0.32% 109
2017
Q1 		$21.1M Buy
460,860
+20,594
+5% +$1.02M 0.24% 164
2016
Q4 		$23.2M Buy
440,266
+118,619
+37% +$5.74M 0.29% 127
2016
Q3 		$14.3M Buy
+321,647
New +$14M 0.25% 169

Other funds holding SYNH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Rothschild & Co Asset Management US's SYNH Position: Q4 2022 in Review

Rothschild & Co Asset Management US sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 74,764 shares — an estimated $3.52M sold.

Rothschild & Co Asset Management US first reported a position in SYNH in Q3 2016 and held it in 25 quarters. The position peaked at $43.7M in Q4 2019. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

  • Rothschild & Co Asset Management US reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Rothschild & Co Asset Management US sold 74,764 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $3.52M.
  • Rothschild & Co Asset Management US first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2016 and held it in 25 quarters.
  • Rothschild & Co Asset Management US's Syneos Health, Inc. Class A Common Stock position peaked at $43.7M in Q4 2019.
  • 307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Rothschild & Co Asset Management US's 13F filing for Q4 2022, filed 14 Feb 2023.